The C-type lectin receptor Dectin-1 plays a pivotal role in antifungal immunity. In this study, the recently characterized human DECTIN1 Y238X early stop codon polymorphism leading to diminished Dectin-1 receptor activity was studied in relation to invasive aspergillosis susceptibility and severity in patients receiving hematopoietic stem cell transplant (HSCT).
Introduction
Aspergillus spp. are ubiquitous in nature and the spectrum of diseases they cause is myriad, including saprophytic colonization of pre-existing cavities (aspergilloma), allergic asthma, hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis occurring as a complication of bronchial asthma or cystic fibrosis, and disseminated disease associated with high mortality rates in patients with hematological malignancies and recipients of solid organs and stem cell transplants 1 . Immunocompetent and non-atopic subjects are relatively resistant to infections and disease occurs in the setting of host damage 2 . The association of persistent inflammation with intractable infection is common in non-neutropenic patients after hematopoietic stem cell transplant (HSCT) as well as in allergic fungal diseases 2 . Current understanding of the pathophysiology underlying Aspergillus infection and disease highlights a truly bipolar nature of the inflammatory process in infection. Early inflammation prevents or limits infection, but an uncontrolled response may eventually oppose disease eradication. This condition is crucially exemplified in mice with Chronic Granulomatous Disease, in which an intrinsic, genetically determined failure to control inflammation to sterile fungal components determines the animals' inability to resolve an actual infection with A. fumigatus 3 . A main implication of these findings is that, at least in specific clinical settings, it is an exaggerated inflammatory response that likely compromises a patient's ability to eradicate infection, and not an 'intrinsic' susceptibility to infection that determines a state of chronic or intractable disease. We have recently found that blocking inflammatory pathways in vivo (namely PI3K/Akt/mTOR) could be exploited for the development of siRNA therapeutics to attenuate inflammation in aspergillosis 4 .
A number of studies have highlighted the importance of Dectin-1 in antifungal immunity, in both mice and humans [5] [6] [7] . Dectin-1 deficiency attenuated the inflammatory response while increasing the lung fungal burden in experimental aspergillosis 8 , a finding largely attributed to defective IL-17 production. However, despite the fact that IL-17-producing cells are present in the peripheral T cell repertoire of humans 9 , it has recently been suggested that anti-Aspergillus human host defense relies on Th1, rather than Th17, cellular immunity 10 . This suggests that the role of Dectin-1 in antifungal immunity may go beyond the promotion of an inflammatory activity eventually leading to fungal clearance and antifungal immunity. In this regard, a recent study has shown that, besides the activation of the Syk-dependent canonical transcription factor NF-κB to induce antifungal immunity, Dectin-1 also activates the noncanonical NF-κB pathway 11 . Given the distinct, yet complementary, role of the canonical/noncanonical NF-κB pathways in immunity and tolerance to Aspergillus 4, 12 , this finding would predict additional, unanticipated activities of Dectin-1 in antifungal immunity and its regulation.
Recently, genetic polymorphisms affecting human Dectin-1 have also been addressed as potential predictive factors for the incidence of fungal infections. A polymorphism in the human DECTIN1 gene (Y238X, rs16910526) that generates an early stop codon was associated with recurrent mucocutaneous fungal infections in a Dutch family 13 and with Candida colonization after HSCT 14 . This polymorphism, leading to the loss of the last 10 amino acids of the extracellular domain of Dectin-1, results in impaired transport to the cell surface as well as failure in mediating β -glucan binding 14 . Although these studies have focused on the role of the DECTIN1 Y238X polymorphism in modulating susceptibility to Candida, the pathological aspects of human Dectin-1 deficiency in the immune response to
Aspergillus are still to be appreciated.
In this study, we have evaluated the association of the DECTIN1 Y238X polymorphism with invasive aspergillosis (IA) in HSCT patients. A side-by-side comparison of Dectin-1 functional deficiency in humans and mice has disclosed Dectin-1 deficiency as a novel susceptibility factor for aspergillosis in high-risk patients.
Materials and methods

Human study population
A total of 205 patients with hematological malignancies who underwent T cell-depleted allogeneic HSCT, and of whom stored donor and patient DNA was available, were included in the genetic association study. Table 1 . Patients with a history of treated pretransplant aspergillosis were excluded from the study. Graft processing and transplantation procedures were performed as previously described 15 . Grafts consisted of immunoselected CD34 + peripheral blood cells in all cases.
No graft-vs.-host-disease (GVHD) prophylaxis or granulocyte-colony stimulating factor (G-CSF) was administered post-transplant. Steroid therapy was administered only to patients that ultimately developed GVHD. The local ethics committee (Comitato Etico delle Aziende Sanitarie dell' Umbria, Perugia) provided institutional review board-approval for this study and informed written consent was obtained from all participants in accordance with the Declaration of Helsinki.
Microbiological and clinical evaluation
Antifungal prophylaxis included liposomal amphotericin-B (1 mg/Kg/daily) in high risk patients and fluconazol (400 mg/daily) in standard risk patients from day -5 until neutropenia ended. The criteria defining high risk for invasive fungal disease at the time of allogeneic HSCT were as follows: i) invasive fungal disease before receipt of transplant (these patients have been excluded from the study), ii) HSCT from an HLA haplotype-mismatched family donor, and iii) HSCT from an HLA-identical sibling, if conditioning included total body irradiation (TBI) 16 . patients (18%). Among the patients with IA, 4 (10%) also developed GVHD.
Genetic screening of the DECTIN1 Y238X polymorphism
Genomic DNA from whole blood samples from patients and donors was isolated before transplant using the QIAamp DNA Blood Mini kit (Qiagen, Italy) following the manufacturer's instructions and stored at -20°C. The DECTIN1 Y238X polymorphism (rs16910526) was selected based on previously published evidence of association with susceptibility to Candida colonization and infection [13] [14] . Genotyping was performed using bidirectional PCR amplification of specific alleles (Bi-PASA), as previously described 18 
Mice
Female C57BL/6 and BALB/c mice, 8-10 wk old, were purchased from Charles River (Calco, Italy). These strains were selected upon the consideration that BALB/c mice present comparable levels of both Dectin-1A and Dectin-1B transcripts, whereas C57BL/6 mice predominantly express the smaller Dectin-1B isoform 19 . Homozygous Dectin-1-deficient mice on both the C57BL/6 and BALB/c backgrounds (kindly supplied by Emiko Kazama, University of Tokyo, Japan) were bred under specific pathogen-free conditions at the Animal Facility of Perugia University, Perugia, Italy. Experiments were performed according to the Italian Approved Animal Welfare Assurance A-3143-01.
Fungal strain and infection
The strain of A. fumigatus was obtained from a fatal case of pulmonary aspergillosis at the Infectious Diseases Institute of the University of Perugia. Viable conidia (>95%) were obtained by growth on Sabouraud dextrose agar (Difco Laboratories, Detroit, MI)
supplemented with chloramphenicol for 4 days at room temperature. Inactivated resting or swollen conidia were obtained as described 20 . For infection, mice were anesthetized by i.p. Biotec, Bergisch Gladbach, Germany). Unbound cells were carefully aspirated, washed, and resuspended at a concentration of 100 × 10 6 cells/ml. Recipient C57BL/6 or BALB/c mice were exposed to a lethal dose of 9 Gy, infused with T cell-depleted donor cells and infected with Aspergillus conidia a week later 9 .
Cytokine production by human PBMCs
Upon written informed consent, human peripheral blood mononuclear cells (PBMCs) isolated from healthy blood donors bearing the wild-type DECTIN1 (n=8) or the heterozygous Y238X allele (n=4) were stimulated with heat-inactivated Aspergillus conidia, β -glucan (5 μ g/mL) 9 or phytohemagglutinin (PHA) for 72 h before determination of cytokine content in the culture supernatant 21 .
siRNA-mediated DECTIN1 silencing in human epithelial cells
The human bronchial epithelial BEAS-2B cells were cultured as described 22 μ g/mL β -glucan, before total cellular RNA isolation and culture supernatants collection.
ELISA and real-time PCR
The level of cytokines in culture supernatants was determined by ELISA (SearchLight Custom Array; Aushon Biosystems, Tema Ricerca Srl). Real-time RT-PCR was performed using the iCycler iQ detection system (Bio-Rad) and SYBR Green chemistry (Finnzymes Oy, Espoo, Finland). Cells were lysed and total RNA was extracted using RNeasy Mini Kit (QIAGEN, Milan, Italy) and was reverse transcribed with Sensiscript Reverse Transcriptase (QIAGEN) according to the manufacturer's directions. The PCR primers were as described 23 .
Amplification efficiencies were validated and normalized against Gapdh. The thermal profile for SYBR Green real-time PCR was at 95 °C for 3 min, followed by 40 cycles of denaturation for 30 s at 95 °C and an annealing/extension step of 30 sec at 60 °C. Each data point was examined for integrity by analysis of the amplification plot. The mRNA-normalized data were expressed as relative cytokine mRNA in stimulated cells compared to that of mock-infected cells. 
Flow cytometry
Results
DECTIN1 Y238X polymorphism affects susceptibility to invasive aspergillosis
To assess the risk of IA according to the DECTIN1 Y238X polymorphism in recipients and donors of HSCT, we estimated the cumulative incidence of IA at 6 and 36 months after transplant. We found that donor Y238X polymorphism was associated with IA at 36 months (cumulative incidence, 38% in the presence of the allele vs. 19% in its absence; P=0.03), although a trend towards an increased risk of IA was also observed at 6 months ( Figure 1A ).
Interestingly, recipient Y238X polymorphism also tended to influence the risk of IA at 36 months (cumulative incidence, 39% in the presence of the allele vs. 20% in its absence;
P=0.11), although in this case, no differences were observed at 6 months after transplant ( Figure 1B) . The fact that risk of IA at 36 months was further increased when the Y238X polymorphism was present simultaneously in both recipients and donors (cumulative incidence, 44% for Y238X pairs vs. 18% for wild-type (WT) pairs; P=0.05) ( Figure 1C) A total of 117 (57%) patients died after transplant, leaving 88 (43%) long-term survivors. Median follow-up time among patients who survived was 28 months (range, 5 to 77) and among those who died was 6 months (range, 1 to 57). Although no statistically significant differences were observed, the probability of survival at 36 months was nevertheless found to decrease from 41% among patients from WT pairs to 23% among patients with the high-risk Y238X/Y238X allele combination ( Figure 1D ).
DECTIN1 Y238X polymorphism associates with defective Dectin-1 activity
To investigate whether the DECTIN1 Y238X polymorphism associates with decreased surface expression of Dectin-1 and altered cytokine production in response to specific ligands, as already reported [13] [14] , we first analyzed membrane-bound Dectin-1 expression in gated CD14 + peripheral monocytes from WT (n=8) or Y238X (n=4) heterozygous individuals by flow cytometry. We found that unstimulated CD14 + monocytes from Y238X individuals display a decreased surface expression of Dectin-1 (76±5%; range, 62-83%) as compared to WT monocytes (91±1%; range, 89-93%) (P=0.02; Figure 2A ). Dectin-1 mRNA expression was instead identical between genotypes (data not shown). Functionally, in response to β -glucan or Aspergillus conidia, PBMCs isolated from individuals heterozygous for the Y238X polymorphism showed a decreased production of IL-1β and IL-6 ( Figure 2B ), as already reported [13] [14] , while no significant variations were observed in the production of TNF-α, CCL3/MIP-1α or CCL4/MIP-1β (data not shown). Interestingly, the results showed that IFN-γ and IL-10, more than IL-17A, productions were also decreased in PBMCs harboring the Thus, we assessed Dectin-1 mRNA expression and cytokine production in BEAS-2B cells upon stimulation with β -glucan or Aspergillus conidia and the effects of Dectin-1 blockade by siRNA. We found that both β -glucan and Aspergillus conidia greatly induced Dectin-1 mRNA ( Figure 3A ) and concomitantly the production of IL-6 and TNF-α ( Figure 3B ) in BEAS-2B cells. However, transfection of cells with a Dectin-1-specific siRNA abrogated both these effects ( Figures 3A and B) . These results suggest that Dectin-1 on ECs is inducible in infection and contribute to the overall cytokine production.
Dectin-1 regulates both resistance and inflammation to Aspergillus in mice
To understand cellular and molecular immune pathways by which the DECTIN1 Y238X polymorphism may affect susceptibility to aspergillosis in HSCT, we resorted to experimental models of pulmonary aspergillosis in which the relative contribution of inflammatory and non-inflammatory cytokine pathways are well characterized [3] [4] 8, 20 . We injected WT and
Dectin-1 KO mice on both the BALB/c and C57BL/6 backgrounds with Aspergillus dormant conidia i.t. and evaluated parameters of susceptibility and resistance to the infection in terms of mortality, fungal growth, inflammatory pathology and cytokine production. The results
show that the fungal burden was higher in KO than WT mice on both backgrounds ( Figure   4A ), even though the infection was eventually cleared in both types of mice and all survived the infection (data not shown). In terms of inflammatory cell recruitment in the BAL and lung histopathology, differences were observed between WT and KO on the two backgrounds ( Figure 4B ). The inflammatory cell recruitment and lung pathology were greatly increased in KO, as compared to WT, mice on the BALB/c background and this was associated with reduced levels of lung IL-10 and, to a lesser extent, of IFN-γ and IL-17A production ( Figure   4C ). In contrast, the inflammatory cell recruitment and lung pathology were less pronounced in KO than WT mice on the C57BL/6 background and this was associated with decreased levels of IFN-γ and IL-17A but less of IL-10 ( Figure 4C ). Confirming the human data, these results indicate that the functional activity of Dectin-1 in infection includes a regulatory function of IL-10 and IFN-γ, in addition to IL-17A, production and is apparently contingent upon host genetic background.
Dectin-1 deficiency affects immunity and tolerance to Aspergillus in HSCT mice
To assess the translational potential of the regulatory activity of Dectin-1 on cytokine production in aspergillosis, we evaluated Th immunity and tolerance to Aspergillus in an experimental model of HSCT in which Dectin-1 KO mice on both genetic backgrounds were used as either donors or recipients or both. As in humans, the susceptibility to the infection increased in conditions of Dectin-1 deficiency. In particular, an unrestricted fungal growth associated with an exuberant inflammatory response and IL-17A production occurred in recipient KO mice, especially on the BALB/c background, in which IFN-γ, but particularly, IL-10 productions were greatly reduced ( Figure 5B ) as compared to recipient WT mice ( Figure 5A ). The susceptibility to the infection was not increased in donor KO-transplanted mice in which a predominant IFN-γ/IL-10 over IL-17A response was observed ( Figure 5C ), a finding suggesting a possible compensatory role for recipient Dectin-1. Indeed, in the condition in which both donor and recipient Dectin-1 KO were used, mice experienced the most severe form of infection, both in terms of unrestricted fungal growth and lung inflammation ( Figure 5D ). These data confirm the crucial role of Dectin-1 in infection and suggest that the contribution of this receptor to antifungal resistance is contingent upon hematopoietic/nonhematopoietic compartmentalization. Dectin-1 on donor cells appears to provide antifungal resistance through IL-17A while on recipients through IFN-γ/IL-10.
Discussion
Although natural immunity ensures survival of the species as a whole, individuals themselves are not likely to be immunocompetent to all pathogens, and individual differences in susceptibility to specific pathogens are quite common 31 . Several polymorphisms in innate immune receptors, most remarkably Toll-like receptors, have been described to influence susceptibility to aspergillosis in distinct settings of patients [32] [33] [34] [35] . In the present study, we found that the functional Y238X polymorphism in DECTIN1 increased susceptibility to IA among HSCT patients, a finding consistent with the role of Dectin-1-mediated mechanisms of host defense against Aspergillus 5, 8, 36 . The increased susceptibility to aspergillosis underlined by the Y238X polymorphism was found to rely on both donor and recipient genetic make-ups, with the effect being more prominent in conditions in which both donors and recipients simultaneously harbored the Y238X polymorphism. In addition, donor Y238X polymorphism appears to increase the risk of either early (0-30 days) or late (30-120 days) infection, while the impact of recipient Y238X occurs on very late periods after transplant (after 120 days).
Although no significant impact of the Y238X polymorphism was demonstrated on OS, a trend towards a poorer prognosis was nevertheless observed for individuals belonging to the highrisk group of Y238X/Y238X donor/recipient pairs. Since no impact of the polymorphism was observed on relapse or GVHD (data not shown), the worsened survival is most likely correlated with the fact that these patients have the highest risk of developing aspergillosis.
The DECTIN1 Y238X polymorphism generates a truncated Dectin-1 protein unable to target the membrane and mediate β -glucan recognition, therefore resulting in defective cytokine production upon receptor engagement [13] [14] . Although Dectin-1 has been regarded as one major innate receptor leading to Th17 activation in response to Aspergillus 8 , and the Y238X polymorphism was associated with impaired IL-17 production in response to Candida albicans or β -glucan 37 and increased Candida colonization in HSCT patients 13 , we found that IFN-γ and IL-10, in addition to IL-1β, IL-6 and IL-17A, productions by PBMCs heterozygous for the Y238X polymorphism were defective upon β-glucan-or Aspergillusspecific stimulation. Results obtained with Dectin-1 KO mice confirmed the regulatory activity of Dectin-1 over IFN-γ and IL-10, more than IL-17A, production. These findings are consistent with the recent observations that multiple, yet distinct, fungal molecules other than β-glucan, are endowed with the ability to activate human Th17 cells 9 . Thus, our study reveals a previously unsuspected role for Dectin-1 in antifungal immunity, that is the ability to modulate immunity and tolerance via IFN-γ/IL-10 production, both cytokines reflecting the activation of protective Th1/Treg antifungal responses in mice 4 and humans 10 .
We have recently shown that the induction of antifungal Th1/Tregs occurs through the noncanonical NF-κB pathway on dendritic cells (DCs) 4 , a pathway also activated by Dectin-1 11 . Therefore, it is tempting to speculate that, by affecting the balance between canonical/noncanonical NF-κB activation on DCs, Dectin-1 may affect the inflammatory state in infection. However, the high risk of infection seen in condition of recipient Dectin-1 deficiency both in humans and murine models, also points to a crucial role for Dectin-1 expressed on nonhematopoietic cells in the induction of immune protection to the fungus. We found that Dectin-1 was inducible on human ECs and contribute to cytokine production in response to the fungus. Evidence suggests that the airway ECs are not simply "innocent bystanders" but may play a crucial role in innate and inflammatory responses 38 19 . We have already disclosed polymorphisms in a number of innate immune genes that modulate susceptibility to IA in T cell-depleted transplanted patients 33, 43 . In addition to the mechanistic insights regarding Dectin-1 function in aspergillosis, the present study further points to the utility of the genetic screening to identify patients at high risk for IA and, whenever possible, for adequate donor selection. 
